argus

Ipca Laboratories Ltd.

NSE: IPCALABINE571A01038₹49,887 Cr

Timeline

Time (IST)TypeMEventSrc
13 Jan, 10:40 am—…Ipca Laboratories Ltd - 524494 - Board Meeting Outcome for Outcome Of Board Meetingbse
05 Dec, 02:33 pm—…IPCA Laboratories Limited has informed the Exchange about Inspection of Company s Active Pharmaceutical Ingredients (APIs) manufacturing facility situated at Tarapur (Palghar-Maharashtra) by US FDAnse
18 Nov, 03:51 pm—…IPCA Laboratories Limited has informed the Exchange about Re-lodgement of transfer requests of physical shares report - October 2025nse
17 Nov, 02:11 pm—…IPCA Laboratories Limited has informed the Exchange regarding 'Clarification sought on Volume Movement by BSE'.nse
17 Nov, 01:55 pm—…Ipca Laboratories Ltd - 524494 - Clarification sought from Ipca Laboratories Ltdbse
17 Nov, 01:07 pm—…IPCA Laboratories Limited has informed the Exchange about Transcriptnse
17 Nov, 01:04 pm—…Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Nov, 05:04 pm—…IPCA Laboratories Limited has informed the Exchange about Link of Recordingnse
13 Nov, 05:03 pm—…Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Nov, 01:45 pm—…Ipca Laboratories Ltd - 524494 - Standalone And Consolidated Q2-H1 FY26 Results And Press Releasebse
13 Nov, 01:42 pm—…IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
13 Nov, 01:40 pm—…Ipca Laboratories Ltd - 524494 - Board Meeting Outcome for Standalone And Consolidated Q2-H1 FY26 Results And Press Releasebse
17 Oct, 05:31 pm—…IPCA Laboratories Limited has informed the Exchange about Slump Sale of Company's APIs and Drug Intermediates Manufacturing unit situated at Ankleshwarnse
17 Oct, 05:29 pm—…IPCA Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 17, 2025.nse
17 Oct, 05:27 pm—…Ipca Laboratories Ltd - 524494 - Slump Sale Of Company''s Apis And Drug Intermediates Manufacturing Unit Situated At Ankleshwarbse
17 Oct, 03:45 pm—…Ipca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30.09.2025bse
16 Oct, 10:49 am—…IPCA Laboratories Limited has informed the Exchange about incorporation of new subsidiary in Germanynse
09 Oct, 05:39 pm—…IPCA Laboratories Limited has informed the Exchange regarding 'Relodgement of physical shares transfer request - Sep 2025'.nse
09 Oct, 05:14 pm—…Ipca Laboratories Ltd - 524494 - Re-Lodgment Of Transfer Requests For Physical Shares - Sep 2025bse
24 Sept, 05:07 pm—…IPCA Laboratories Limited has informed the Exchange regarding a press release dated September 24, 2025, titled "Technology Transfer Agreement".nse
24 Sept, 04:56 pm—…Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
10 Sept, 05:48 pm—…IPCA Laboratories Limited has informed the Exchange about General Updatesnse
10 Sept, 05:42 pm—…Ipca Laboratories Ltd - 524494 - Relodgement Of Transfer Request For Physical Sharesbse